-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LhXgrY6IpNeD6A66CMVEBt9Rzlav3b5Uhooo0EtUKdOJwFGgYsWTZl5jFLeDdBTN AEOwZc5MEiZmuVv0o/Ac+g== 0001144204-07-028519.txt : 20070524 0001144204-07-028519.hdr.sgml : 20070524 20070524161458 ACCESSION NUMBER: 0001144204-07-028519 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20070524 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20070524 DATE AS OF CHANGE: 20070524 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VARIAN MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000203527 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 942359345 STATE OF INCORPORATION: DE FISCAL YEAR END: 0905 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07598 FILM NUMBER: 07877108 BUSINESS ADDRESS: STREET 1: 3100 HANSEN WAY CITY: PALO ALTO STATE: CA ZIP: 94304-1000 BUSINESS PHONE: 6504934000 MAIL ADDRESS: STREET 1: 3050 HANSEN WAY STREET 2: MAIL STOP E 224 CITY: PALO ALTO STATE: CA ZIP: 94304-1000 FORMER COMPANY: FORMER CONFORMED NAME: VARIAN ASSOCIATES INC /DE/ DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: VARIAN DELAWARE INC DATE OF NAME CHANGE: 19761123 8-K 1 v076649_8k.htm Unassociated Document

SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934



Date of report (Date of earliest event reported)
May 24, 2007


 
VARIAN MEDICAL SYSTEMS, INC.
(Exact Name of Registrant as Specified in its Charter)
 

 
Delaware
1-7598
94-2359345
(State or Other Jurisdiction
of Incorporation)
(Commission File
Number)
(IRS Employer
Identification No.)


3100 Hansen Way, Palo Alto, CA
94304-1030
(Address of Principal Executive Offices)
(Zip Code)


Registrant's telephone number, including area code
(650) 493-4000


Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 


 


 

Item 8.01. Other Events
 
On May 24, 2007, Varian Medical Systems, Inc. issued a press release regarding the completion of its acquisition of Bio-Imaging Research, Inc. A copy of the press release is attached as Exhibit 99.1 and incorporated by reference into this item.
 
Item 9.01. Financial Statements and Exhibits.
 
(c) Exhibits.
 
99.1 Press Release dated May 24, 2007 entitled “Varian Medical Systems Completes Acquisition of Bio-Imaging Research.”
 
 


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
  Varian Medical Systems, Inc.
 
 
 
 
 
 
  By:   /s/ JOHN W. KUO
 
Name: John W. Kuo
  Title: Corporate Vice President, General Counsel and Secretary 

Dated: May 24, 2007

 

 
EXHIBIT INDEX
 

Number
Exhibit
99.1
Press Release dated May 24, 2007 entitled “Varian Medical Systems Completes Acquisition of Bio-Imaging Research.”
 
 

 
EX-99.1 2 v076649_ex99-1.htm Unassociated Document
Exhibit 99.1

FOR INFORMATION CONTACT:
Varian Medical Systems
Spencer Sias (650) 424-5782
 
For Immediate Release
 
 
Varian Medical Systems Completes Acquisition of Bio-Imaging Research
 
PALO ALTO, Calif., May 24, 2007 - Varian Medical Systems, Inc., (NYSE:VAR) today announced it has completed the acquisition of Bio-Imaging Research, Inc., a supplier of X-ray imaging products for security and inspection. Varian paid approximately $21 million to acquire the privately-held business based in Lincolnshire, IL. 
 
“This acquisition enables Varian to offer customers more complete X-ray imaging solutions for cargo screening, industrial inspection and non-destructive testing,” said Tim Guertin, president and CEO of Varian Medical Systems. “With BIR’s components and software for capturing, processing and analyzing X-ray images, we are offering a complete imaging solution for security and inspection as well as complete systems for non-destructive testing.”
 
BIR, which has approximately 50 employees, will operate within Varian’s Security and Inspection Products (SIP) unit and report to SIP General Manager Robert Drubka.
 
Varian expects that BIR will add revenues of approximately $5 million for the remainder of fiscal 2007 and that it will be nearly neutral to earnings per diluted share in fiscal 2007. Results for BIR will be included with SIP results in Varian’s “Other” business category.
 
# # #
 
Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 4,200 people who are located at manufacturing sites in North America and Europe and in its 56 sales and support offices around the world.
 
Forward Looking Statements:
Except for historical information, this news release contains "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements concerning customer demand and acceptance of products or technology for proton therapy, and the outlook for Varian’s orders, sales, backlog, or earnings growth; future financial results and any statements using the terms "will," “expects,” “opportunity,” or similar statements are forward-looking statements that involve risks and uncertainties that could cause Varian’s actual results to differ materially from those anticipated. Such risks and uncertainties include the ability to integrate the operations of BIR into Varian and to integrate BIR’s products into Varian’s products, the ability to retain the services of key BIR management and technical personnel; demand for Varian’s and BIR’s products; Varian’s ability to develop and commercialize new products; the impact of competitive products and pricing; Varian’s ability to maintain or increase operating margins; Varian’s ability to protect its intellectual property; the risk of operations interruptions due to events beyond Varian’s control; and the other risks listed from time to time in Varian’s filings with the Securities and Exchange Commission. We assume no obligation to update or revise the forward-looking statements in this release because of new information, future events, or otherwise.

-----END PRIVACY-ENHANCED MESSAGE-----